SEC
SlamSEC
SearchBrowseEarnings

Accelerate Diagnostics, Inc

Laboratory Analytical Instruments·TUCSON, AZ
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

CEO
Phillips Jack
CFO
Patience David
Revenue
$12.1M
+2.4% YoY
FY 2024
Adj. EBITDA
-$52.7M
-437.3% margin
FY 2024
Net Income
-$61.6M
-511.0% margin
FY 2024
EPS (Diluted)
-$4.94
FY 2024
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$12.1M
FY 2024
Total Debt
$4.7M
FY 2021
Net Cash
$7.5M
FY 2021
Enterprise Value
—
Debt / EBITDA
0.1x
FY 2024
EV / EBITDA
—
Employees
—